| 000 | 01874cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030352.0 | ||
| 008 | 110313s2010 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.28.M.Sc.2010.Di.R | ||
| 100 | 0 | _aDina Hassan Mahmoud Elbeheiry | |
| 245 | 1 | 0 |
_aRole of IVIG reduction of morbidity and mortality in neonatal sepsis / _cDina Hassan Mahmoud Elbeheiry ; Supervised Amany Mohammed Elwan , Nouran Fahmy Hussein , Aliaa Adel Ali |
| 246 | 1 | 5 | _aدور الاجسام المضادة فى علاج التسمم الجرثومى عن طريق الحقن الوريدى فى خفض نسبة الوفيات والاعتلال فى الاطفال حديثى الولادة |
| 260 |
_aCairo : _bDina Hassan Mahmoud Elbeheiry , _c2010 |
||
| 300 |
_a120P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics | ||
| 520 | _aSepsis is a major cause of morbidity and mortality in the neonatal period inspite of extensive use of antimicrobial therapy . Sepsis related mortality and mortality rates are high among preterm infants especially in the smallest neonates . The increased risk of severe neonatal infections in the extremely preterm infant is thought to be attributable to immature defense mechanisms in combination with the use of invasive treatment techniques | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aIVIG treatment | |
| 653 | 4 | _aNeonatal sepsis | |
| 653 | 4 | _aReduction of morbidity | |
| 700 | 0 |
_aAliaa Adel Ali , _eSupervisor |
|
| 700 | 0 |
_aAmany Mohammed Elwan , _eSupervisor |
|
| 700 | 0 |
_aNouran Fahmy Hussein , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c33271 _d33271 |
||